Kintu K, Malaba T, Nakibuka J, et al. RCT of Dolutegravir vs Efavirenz-based therapy initiated in late pregnancy: DOLPHIN-2. CROI 2019, abstract 40-LB.
Veiligheid en immunogeniciteit van 1 versus 2 doses tetravalent denguevaccin
sep 2017 | Virale infecties